Kumar Amit's Form 4 filing
Anixa Biosciences Inc (ANIX) · filed Aug 3, 2026
- Accession no.
- 0001493152-26-035751
- Filed
- Aug 3, 2026, 8:45 AM ET
- Trade date
- Jul 31, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $17.4K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kumar AmitCIK 0001191905 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | Common Stock | PPurchaseAcquired | +5,000 | $3.47 | +$17,350 | 657,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.